Autonomix Medical appointed Sandra Kalter as an independent director on September 14, 2026, expanding its board and adding medical-device regulatory experience. The appointment matters to investors because the company says she will provide strategic guidance as it advances its technologies, clinical development and discussions with potential industry partners.
Key Highlights
- Sandra Kalter served as Medtronic’s Chief Regulatory Counsel and Vice-President from 2011 to 2025.
- Kalter was a Strategic Advisor to iTolerance from 2025 to 2026.
- She has not been appointed to any board committees at this time.
Autonomix Medical, Inc. (NASDAQ: AMIX) appointed Sandra Kalter as an independent director on September 14, 2026. The addition gives the board expertise in medical-device regulation, clinical matters, quality systems and technology evaluation as Autonomix advances its platform.
Kalter Adds Regulatory and Medical-Device Experience
Kalter held senior Leadership roles at Medtronic from 2005 to 2025, most recently serving as Chief Regulatory Counsel and Vice-President from 2011 to 2025. Her responsibilities included legal strategy covering global regulatory, quality, clinical, promotion and advertising, as well as medical safety. She also served as a Strategic Advisor to iTolerance from 2025 to 2026. Kalter has served on boards and committees including AdvaMed, the Food and Drug Law Institute and Breakthrough T1D. She participated in AdvaMed’s Legal Committee through 2025 and co-chaired its Advertising and Promotion Working Group and Off Label Working Group. She has not been appointed to any committees of Autonomix’s board at this time.
Board Role Supports Clinical Development
The company says Kalter’s experience will support its work toward clinical development and broader industry partnerships.
FAQs
Q: Who is Sandra Kalter at Autonomix Medical?
A: Sandra Kalter is an independent director of Autonomix Medical. She previously served as Medtronic’s Chief Regulatory Counsel and Vice-President and has held medical-device regulatory leadership roles.
Q: When did Autonomix Medical appoint Sandra Kalter?
A: Autonomix Medical appointed Sandra Kalter on September 14, 2026. Her appointment took effect immediately, and she joined the company’s standard compensation program for non-employee directors.
Q: What education does Sandra Kalter have?
A: The article does not state what education Sandra Kalter has. It describes her regulatory, clinical, quality-systems and medical-device experience instead.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.